PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
10-May-2022 Paradigm4 launches REVEAL: Proteomics to transform protein bio-marker research Paradigm4
10-May-2022 Introducing a new industry standard with new Crystal16 Technobis Crystallization Systems
09-May-2022 Mdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journey mdgroup
05-May-2022 New EFSA opinion offers future FSMP application potential for Bimuno® prebiotic ingredient Clasado Biosciences
05-May-2022 ADVANZ PHARMA to acquire Intercept’s business in Europe, Canada, and all other markets outside of the U.S. ADVANZ PHARMA
04-May-2022 Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger Phesi
04-May-2022 Foundation S: Sanofi’s new philanthropic spearhead Sanofi
04-May-2022 Seung Jae Lee, CEO of C&L Therapeutics - I Chose to Collaborate to Create a Luxury New Drug Jubilant Biosys
03-May-2022 JYSELECA®▼ (filgotinib), recommended by the Health Service Executive (HSE) for people with Ulcerative Colitis (UC) in Ireland Galapagos Biotech LTD
28-Apr-2022 AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem AARDEX® Group
26-Apr-2022 Symeres acquires Organix Inc., adding lipids expertise and a strategic foothold in the US Symeres
26-Apr-2022 Gloucestershire Hospitals NHS Foundation Trust Future-proofs Clinical Pathology Pathway in First of Type Deployment with InterSystems LIMS Gloucestershire Hospitals NHS Foundation Trust
26-Apr-2022 SOTIO Initiates CLAUDIO-01 Trial with Antibody-Drug Conjugate SOT102 in Patients with Gastric and Pancreatic Cancer SOTIO
21-Apr-2022 PacBio and Children’s Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease PacBio
21-Apr-2022 Evusheld significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations AstraZeneca
19-Apr-2022 PHASTAR Names Ping-Chung Chang as Head of China Development and Global Delivery PHASTAR
19-Apr-2022 ADVANCED CLINICAL CONTINUES GLOBAL EXPANSION INTO EUROPE WITH NEW OFFICE IN SWITZERLAND ADVANCED CLINICAL
19-Apr-2022 Clinerion adds Patient Network Explorer coverage to three new hospitals in Brazil, bringing the Brazilian total to 22 hospitals and over 8 million patients. Clinerion Ltd.
13-Apr-2022 Celerion Announces Investment in ADME Suite of Services Celerion
13-Apr-2022 CD Bioparticles Launches Dendrons for Drug Delivery Research CD Bioparticles